MOST: THE MELANOMA OBSERVATIONAL STUDY Trademark

Trademark Overview

On Tuesday, July 26, 2011, a trademark application was filed for MOST: THE MELANOMA OBSERVATIONAL STUDY with the United States Patent and Trademark Office. The USPTO has given the MOST: THE MELANOMA OBSERVATIONAL STUDY trademark a serial number of 85380946. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 15, 2014. This trademark is owned by Bristol-Myers Squibb Company. The MOST: THE MELANOMA OBSERVATIONAL STUDY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
most: the melanoma observational study

General Information

Serial Number85380946
Word MarkMOST: THE MELANOMA OBSERVATIONAL STUDY
Filing DateTuesday, July 26, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 15, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2011

Trademark Statements

Disclaimer with Predetermined Text"THE MELANOMA OBSERVATIONAL STUDY"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 29, 2011
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, September 15, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 15, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 11, 2014EXTENSION 4 GRANTED
Friday, February 14, 2014EXTENSION 4 FILED
Friday, February 14, 2014TEAS EXTENSION RECEIVED
Tuesday, August 27, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 26, 2013EXTENSION 3 GRANTED
Wednesday, August 14, 2013EXTENSION 3 FILED
Wednesday, August 14, 2013TEAS EXTENSION RECEIVED
Wednesday, April 3, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 31, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, January 30, 2013EXTENSION 2 GRANTED
Tuesday, January 15, 2013EXTENSION 2 FILED
Wednesday, January 30, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 15, 2013TEAS EXTENSION RECEIVED
Wednesday, July 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, July 23, 2012EXTENSION 1 GRANTED
Monday, July 23, 2012EXTENSION 1 FILED
Monday, July 23, 2012TEAS EXTENSION RECEIVED
Tuesday, February 14, 2012NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2011NOTICE OF PUBLICATION
Thursday, November 17, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 17, 2011ASSIGNED TO LIE
Tuesday, October 25, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 24, 2011EXAMINER'S AMENDMENT MAILED
Monday, October 24, 2011EXAMINER'S AMENDMENT ENTERED
Monday, October 24, 2011EXAMINERS AMENDMENT -WRITTEN
Thursday, October 13, 2011ASSIGNED TO EXAMINER
Friday, July 29, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 29, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

study observational melanoma most relating pharmaceutical preparations human trials clinical scientific research namely conducting